MedTrace Logo

Intracardiac Flow Assessment in Cardiac Amyloidosis

NCT05379101 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2025-07-14

No results posted yet for this study

Summary

The primary objective of this study is to define the intracardiac flow imaging biomarkers in cardiac amyloidosis.

Conditions

  • Amyloidosis Cardiac
  • Healthy Adults

Interventions

DIAGNOSTIC_TEST

Cardiac magnetic resonance image (CMR)

A magnetic resonance imaging study for assessment of cardiac structure and intracardiac flow

DIAGNOSTIC_TEST

Transthoracic Echocardiogram (TTE)

An imaging test that uses soundwaves that cannot be heard (ultrasound) to take pictures of the heart and vessels.

DIAGNOSTIC_TEST

Six-minute Walk Test

A self-paced, test of exercise capacity performed unencouraged intensity that measures the distance that patients can walk on a flat, hard surface in a period of 6 minutes

Sponsors & Collaborators

Principal Investigators

  • Ian C Chang, MD · Mayo Clinic

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-07-20
Primary Completion
2026-05-31
Completion
2026-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05379101 on ClinicalTrials.gov